Background. To establish the clinical and immunological features of the manifestations of allergic diseases in children with IgE-mediated sensitization to potato. Methods. allergy tests (skin prick tests and / or the determination of specific IgE in serum by ImmunoCap, Phadia was performed in 171 children with allergic diseases, who had sensitization to food plant proteins. Results. sensitization to the potato found in 134 children. significant discrepancies (36%) in the results of in vitro and in vivo tests to the potatoes were shown. sensitization to the potatoes is more common in patients with atopic dermatitis (ad), especially in severe disease. among children with the level of specific IgE antibodies to potato ≥2 kUa / l there were more common patients with severe ad. the correlation between the level of specific IgE antibodies to the potatoes and some of food plant proteins was found. the relationship between the concentration of specific IgE to the potatoes and Bet v 2 was not detected. Conclusion. the presence and concentration of specific IgE to the potatoes to a certain extent associated with clinical manifestations of ad. the data obtained substantiate the determination of specific IgE antibodies to potato in children with ad, especially in severe cases.

No abstract

Background. Allergic diagnosis is based on accurate clinical history and conducting of skin prick tests (sPt) and specific IgE determination. the past decade recombinant allergen components from pollen of birch are available for allergen-specific IgE antibody testing. the major allergen of birch tree pollen is Bet v 1; Bet v 2 is a well described minor allergen. Methods. 83 patients with birch pollinosis (55 male/28 female, age 4-35 years, mean 15,5) were observed. specific IgE levels were determined by using the ImmunoCap (Phadia, sweden); skin prick tests with standard aeroallergens panel was used. Results. All 83 patients had positive skin tests to birch pollen. the levels of specific IgE to rBet v1 had 87,9% of patients, sIgE to rBet v 2 (profilin) 14,5% of patients, sIgE to rBet v 1 and rBet v 2 13,3% of patients. Conclusion. the prevalence of the patients with presence of IgE - antibodies to profiling Bet v2 among citizens of moscow region, sensitized to birch, accounts 14,5%.

Allergic rhinitis (AR) is a common childhood disease. At the same time, there is an underdiagnosis of this condition in the clinical practice and its significant impact on the life quality of the patient and his family. The article describes a modern stepwise approach in complex AR therapy in children. This approach involves the choice of drug therapy in accordance with the disease course. In this case, it is necessary, in particular, to take into account the clinically significant sensitization profile, the presence of concomitant allergic and non-allergic pathology, the patterns of the expected exposure of relevant allergens, the disease course severity, the patient’s age, response to therapy, etc. The current problems of conservative treatment are discussed. Information on the pharmacological drug groups for the AR treatment is presented: H1-antagonists, antileukotriene drugs, intranasal glucocorticosteroids. The main effects and the most common adverse events of their usage are considered. Practical issues of AR treatment tactics, relevant for pediatricians, allergists and otorhinolaryngologists, are highlighted. The prescription of drug combinations of different groups is substantiated, providing a simultaneous effect on different links of the pathogenetic process. The importance of elimination measures and allergen-specific immunotherapy is noted. KEYWORDS: allergic rhinitis, sensitization, H1-antagonists, leukotriene receptor antagonists, glucocorticosteroids, children. FOR CITATION: Asmanov A.I., Konyukova N.G., Pivneva N.D. et al. Comprehensive treatment method for children with allergic rhinitis. Russian Medical Inquiry. 2021;5(5):348–352 (in Russ.). DOI: 10.32364/2587-6821-2021-5-5-348-352.